August 11, 2023
FDA: Class I recall of Cardiosave Hybrid, Rescue IABPs
Editor's Note
The Food and Drug Administration (FDA), on August 10, identified the recall by Datascope/Maquet/Getinge of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious.
The recall was initiated because the pumps may shut down unexpectedly due to electrical failures in the Power Management Board or Solenoid Board (Power Source Path).
The company reports 26 complaints, no injuries, and no deaths associated with this issue.
Distribution dates were March 6, 2012, to May 19, 2023.
Free Daily News
- Hospitals boost cybersecurity budgets, staff
- Kentucky passes first-ever state law decriminalizing medical mistakes
- Kaiser Permanente data breach affects 13.4 million
- Study explores link between diverticulitis and colorectal cancer
- State lawmakers target rising healthcare costs via legislation on hospital facility fees
- FDA medical device Class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery
- AAMI guidance covers sterile processing of dilators, ultrasound probes
- Surgical site infections often caused by preexisting bacteria
- The Joint Commission launches new telehealth accreditation program
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging